Your browser doesn't support javascript.
loading
A quantitative approach for measuring the reservoir of latent HIV-1 proviruses.
Bruner, Katherine M; Wang, Zheng; Simonetti, Francesco R; Bender, Alexandra M; Kwon, Kyungyoon J; Sengupta, Srona; Fray, Emily J; Beg, Subul A; Antar, Annukka A R; Jenike, Katharine M; Bertagnolli, Lynn N; Capoferri, Adam A; Kufera, Joshua T; Timmons, Andrew; Nobles, Christopher; Gregg, John; Wada, Nikolas; Ho, Ya-Chi; Zhang, Hao; Margolick, Joseph B; Blankson, Joel N; Deeks, Steven G; Bushman, Frederic D; Siliciano, Janet D; Laird, Gregory M; Siliciano, Robert F.
Affiliation
  • Bruner KM; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Wang Z; Department of Molecular Biosciences, University of Texas, Austin, TX, USA.
  • Simonetti FR; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Bender AM; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Kwon KJ; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Sengupta S; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Fray EJ; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Beg SA; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Antar AAR; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Jenike KM; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Bertagnolli LN; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Capoferri AA; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Kufera JT; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Timmons A; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Nobles C; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Gregg J; Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Wada N; Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Ho YC; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Zhang H; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Margolick JB; Department of Microbial Pathogenesis, Yale School of Medicine, New Haven, CT, USA.
  • Blankson JN; Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Deeks SG; Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Bushman FD; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Siliciano JD; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Laird GM; Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Siliciano RF; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Nature ; 566(7742): 120-125, 2019 02.
Article in En | MEDLINE | ID: mdl-30700913
ABSTRACT
A stable latent reservoir for HIV-1 in resting CD4+ T cells is the principal barrier to a cure1-3. Curative strategies that target the reservoir are being tested4,5 and require accurate, scalable reservoir assays. The reservoir was defined with quantitative viral outgrowth assays for cells that release infectious virus after one round of T cell activation1. However, these quantitative outgrowth assays and newer assays for cells that produce viral RNA after activation6 may underestimate the reservoir size because one round of activation does not induce all proviruses7. Many studies rely on simple assays based on polymerase chain reaction to detect proviral DNA regardless of transcriptional status, but the clinical relevance of these assays is unclear, as the vast majority of proviruses are defective7-9. Here we describe a more accurate method of measuring the HIV-1 reservoir that separately quantifies intact and defective proviruses. We show that the dynamics of cells that carry intact and defective proviruses are different in vitro and in vivo. These findings have implications for targeting the intact proviruses that are a barrier to curing HIV infection.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CD4-Positive T-Lymphocytes / Carrier State / HIV Infections / HIV-1 / Proviruses / Virus Latency / Defective Viruses Limits: Humans Language: En Journal: Nature Year: 2019 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CD4-Positive T-Lymphocytes / Carrier State / HIV Infections / HIV-1 / Proviruses / Virus Latency / Defective Viruses Limits: Humans Language: En Journal: Nature Year: 2019 Document type: Article Affiliation country:
...